These publications were authored or co-authored by Quest Diagnostics staff.
Cost-effectiveness model of use of genetic testing as an aid in assessing the likely benefit of aspirin therapy for primary prevention of cardiovascular disease.Authors: Shiffman D, Slawsky K, Fusfeld L, Devlin JJ, Goss TF.
Clin Ther. 2012;34:1387-1394.
The sensitivity and specificity of hyperglycosylated hCG (hhCG) levels to reliably diagnose clinical IVF pregnancies at 6 days following embryo transfer.Authors: Strom CM, Bonilla-Guererro R, Zhang K, Doody KJ, Tourgeman D, Alvero R, Cedars MI, Crossley B, Pandian R, Sharma R, Neidich J, Salazar D.
J Assist Reprod Genet. 2012;29:609-614.
Humoral, mucosal and cell-mediated immunity against vaccine and non-vaccine genotypes after administration of quadrivalent human papillomavirus vaccine to HIV-infected children.Authors: Weinberg A, Song LY, Saah A, Brown M, Moscicki AB, Meyer WA, III, Bryan J, Levin MJ.
J Infect Dis. 2012.
Performance of an alternative laboratory-based algorithm for diagnosis of HIV infection utilizing a third generation immunoassay, a rapid HIV-1/HIV-2 differentiation test and a DNA or RNA-based nucleic acid amplification test in persons with established HIV-1 infection and blood donors.Authors: Wesolowski LG, Delaney KP, Hart C, Dawson C, Owen SM, Candal D, Meyer WA, III, Ethridge SF, Branson BM.
J Clin Virol. 2011;52 Suppl 1:S45-S49.
Specialties: Infectious Disease
Am J Obstet Gynecol. 2012;207:55-58.
J Clin Endocrinol Metab. 2012;97:777-784.